Pharmacies and pharmacists (“Licensees”) are subject to disciplinary action in each state in which they hold an active license. Moreover, for those holding licenses in multiple states, disciplinary actions in one jurisdiction can lead a separate... Read More
Blogs & Articles | Life Sciences | Pharmacy Law | State Board of Pharmacy Hearings and Professional Discipline

Inventory maintenance, a routine undertaking in most businesses, is among the most crucial tasks performed by pharmacists and may have profound repercussions if not handled accurately.  In particular, inventory shortages are common discrepancies... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

Question: What could be worse than a PBM audit? Answer: A PBM audit coupled with a State Board of Pharmacy investigation. As we have written on previously, Frier Levitt is witnessing an uptick in PBM-initiated complaints to State Boards of... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | National Board of Pharmacy Matters

Frier Levitt Pharmacist-Attorney, Dae Y. Lee, Pharm.D., Esq., CPBS was recently referenced in an article for the March 24, 2021 issue of Total Pharmacy from his session for the Pharmacists Education on CBD & Cannabinoids Symposium on March 19,... Read More
Blogs & Articles | Community, Retail Pharmacies | Life Sciences | News & Press | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

The last few years have brought on a slew of litigation aimed at combatting the opioid epidemic. Most recently, however, a complaint has been lodged against the United States, which has great potential to shape future litigation. Specifically, on... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Federal and State Fraud and Abuse Counseling | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

The Department of Justice (“DOJ” or the “Government”) and Bartell Drug, Inc. (“Bartell”), a Washington State pharmacy chain of approximately 70 pharmacies, recently reached a civil settlement in which Bartell agreed to pay a fine... Read More
Blogs & Articles | Chain Pharmacies | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

As the opioid crisis continues to result in devastating consequences throughout the country, the U.S. Department of Justice (the “DOJ”) is broadening its opioid enforcement to all stakeholders involved in the opioid supply chain including,... Read More
Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

The role of the pharmacist is continuously evolving. President Trump's October 2019 Executive Order 13890, which seeks to improve access to healthcare for Medicare patients, sparked arguments from the National Community Pharmacists Association... Read More
Chain Pharmacies | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences | Pharmacy Law | Specialty Pharmacies